Harman Finochem has 2 state-of-the-art manufacturing facilities that have been inspected by USFDA & WHO-GMP. Supported by a well qualified and strong technical team, the manufacturing facilities comply to cGMP requirement as per ICH Q7 A, with customized particle size options viz. Milling & Micronising. The in-house QC laboratories are equipped with sophisticated instruments to assure high quality standards of APls. The company believes in quality by design and continuous improvement in all aspects of its operations.
A new project is identified and mutual secrecy agreement is signed. Data technical and marketing aspects are exchanged. Harman evaluates the project based on the data and offers a quote after feasibility study and on mutual consern contract, will go ahead with lab / pilot and then commercial production. Along with this phase, a drug master file (DMF) will also be prepared as per new CTD format for Regulatory approvals.
At Harman we follow all safety norms and measures. We have a well equipped storage room with proper hygiene.
